Yingying Zhao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Glycemic Control

Top Venues

EMBO molecular medicine

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine (2024)
Jun Qin, Yingying Zhao, Shumin Li, Qian-Qi Liu, Songming Huang, Xiao-Wen Yu
GDH1 exacerbates renal fibrosis by inhibiting the transcriptional activity of peroxisome proliferator-activated receptor gamma. The FEBS journal (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)